Verified Nov 2026
Other
·
Nice, Provence-Alpes-Cote d'Azur
·
Since 2003
Horus Pharma is an independent French pharmaceutical laboratory founded in 2003 and headquartered in Nice, Provence-Alpes-Cote d'Azur, France. It has an estimated 200-500 employees and an estimated revenue band of $100-250M. The company is privately held and focuses on ophthalmology, serving eye health, dermatology, and related pharmaceutical markets across Europe. In October 2025 it announced a biosimilar aflibercept agreement with Formycon, and in June 2026 it reported entering the age-related macular degeneration (AMD) market.
Horus Pharma at a glance
Revenue
$100-250M
Est. band
Employees
200-500
Founded
2003
Headquarters
Nice, Provence-Alpes-Cote d'Azur
Industries
Automotive
Electric Vehicles
Construction
Medical
Renewable Energy
Industrial Equipment
Overview
Horus Pharma is an independent French pharmaceutical laboratory founded in 2003 and headquartered in Nice, Provence-Alpes-Cote d'Azur, France. It has an estimated 200-500 employees and an estimated revenue band of $100-250M. The company is privately held and focuses on ophthalmology, serving eye health, dermatology, and related pharmaceutical markets across Europe. In October 2025 it announced a biosimilar aflibercept agreement with Formycon, and in June 2026 it reported entering the age-related macular degeneration (AMD) market.
At a glance
Attribute | Detail |
|---|---|
Founded | 2003 |
Headquarters | Nice, Provence-Alpes-Cote d'Azur |
Employees | 200-500 |
Revenue | $100-250M (estimated) |
What Horus Pharma makes
The company's product range, as described in its public profile, includes preservative-free ophthalmic solutions, corneal repair products, contact lens care, and dermatological solutions for eyelid health, and it operates a tissue bank in France.
Products and capabilities described on the company's own site include Plastic (source: horus-pharma.com).
Latest developments
2026-06-17 — Horus Pharma entre sur le marché stratégique de la DMLA (lejournaldesentreprises.com)
2026-04-29 — Horus Pharma joins MedFrance | Horus Pharma (horus-pharma.com)
2026-03-18 — Communiqués de presse | Horus Pharma (horus-pharma.com)
2025-11-15 — Médaille argent EcoVadis pour nos engagements RSE | Horus Pharma (horus-pharma.com)
2025-10-23 — Aflibercept biosimilar deal with Formycon | Horus Pharma (horus-pharma.com)
2025-09-17 — Horus Pharma becomes additional commercialization partner for Formycon's Eylea® biosimilar FYB203 in selected European countries under the brand name Baiama® - Formycon AG (formycon.com)
Company details
The company reports an earned EcoVadis silver medal for its corporate social responsibility commitments, and it operates subsidiaries in several European countries. Horus Pharma was founded in 2003, has an estimated 200-500 employees, and is headquartered in Nice, Provence-Alpes-Cote d'Azur.
Frequently asked questions
What does Horus Pharma do?
Horus Pharma is an independent French pharmaceutical laboratory founded in 2003 and headquartered in Nice, Provence-Alpes-Cote d'Azur, France. It has an estimated 200-500 employees and an estimated revenue band of $100-250M. The company is privately held and focuses on ophthalmology, serving eye health, dermatology, and related pharmaceutical markets across Europe. In October 2025 it announced a biosimilar aflibercept agreement with Formycon, and in June 2026 it reported entering the age-related macular degeneration (AMD) market.
Where is Horus Pharma headquartered?
Horus Pharma is headquartered in Nice, Provence-Alpes-Cote d'Azur.
When was Horus Pharma founded?
Horus Pharma was founded in 2003.
How big is Horus Pharma?
Horus Pharma has an estimated 200-500 employees, with revenue in the $100-250M range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.